The ACTBL2 Knockout HeLa Polyclonal Cells product provides a CRISPR/Cas9-edited polyclonal knockout cell population in which the ACTBL2 gene has been disrupted. This pool of edited HeLa cells offers a robust loss-of-function model for investigating the roles of beta-actin-like protein 2 in cytoskeletal organization and cell migration. As a polyclonal population, it retains genetic heterogeneity while ensuring broad target-gene disruption, making it suitable for diverse functional assays without the need for single-cell cloning.
The host cell line is the widely characterized HeLa cell, a human cervical epithelial cell line originally derived from a cervical adenocarcinoma of Henrietta Lacks. HeLa cells are a cornerstone model in cancer biology, particularly for studying cervical cancer progression and metastasis. Their robust growth and well-documented signaling pathways provide a consistent platform for interrogating actin regulatory mechanisms.
ACTBL2 encodes beta-actin-like protein 2, an actin isoform implicated in cytoskeletal dynamics and cell motility. It operates downstream of Rho family GTPases??RhoA, Rac1, and Cdc42??and is transcriptionally controlled by serum response factor (SRF). ACTBL2 interacts with profilin, cofilin, the Arp2/3 complex, and vinculin, key components of the RhoA/ROCK/LIMK/cofilin axis and the Rac1/WAVE/Arp2/3 pathway. Through these interactions, ACTBL2 mediates F-actin polymerization, filamentous actin architecture, and cell adhesion complex assembly. Consequently, its disruption is anticipated to impair actin cytoskeletal organization and integrin/FAK/Src signaling, perturbing focal adhesion dynamics.
In the context of HeLa cells, ACTBL2 knockout provides a relevant model for studying cervical adenocarcinoma cell migration and metastatic behavior. Since ACTBL2 contributes to actin-based motility and adhesion, its loss likely attenuates cellular migration and invasion, mirroring potential defects in metastatic dissemination. This makes the model particularly valuable for dissecting the molecular underpinnings of cervical cancer metastasis and for screening anti-metastatic compounds.
Researchers can employ this knockout cell pool in Western blotting to assess actin isoform levels, immunofluorescence for F-actin visualization, wound-healing and transwell migration assays, adhesion assays, and Rho GTPase activity measurements. RNA-seq analysis can further elucidate downstream transcriptional changes. Key applications include cancer cell migration studies, cytoskeleton dynamics research, metastasis mechanism investigations, and drug target validation for actin-related therapies. For additional information or to discuss custom applications, please contact Ascent Research.
